Bill Text: TX HB1225 | 2019-2020 | 86th Legislature | Enrolled


Bill Title: Relating to the re-creation of the Chronic Kidney Disease Task Force.

Spectrum: Slight Partisan Bill (Republican 5-2)

Status: (Passed) 2019-06-14 - Effective on 9/1/19 [HB1225 Detail]

Download: Texas-2019-HB1225-Enrolled.html
 
 
  H.B. No. 1225
 
 
 
 
AN ACT
  relating to the re-creation of the Chronic Kidney Disease Task
  Force.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  This Act shall be known as the Glenda Dawson Act.
         SECTION 2.  The state finds that the treatment of chronic
  kidney disease is a tremendous expense and that the early diagnosis
  and effective treatment of chronic kidney disease can prolong lives
  and delay the high cost of medical treatment, including dialysis
  and transplantation.
         SECTION 3.  Subtitle D, Title 2, Health and Safety Code, is
  amended by adding Chapter 83 to read as follows:
  CHAPTER 83. CHRONIC KIDNEY DISEASE TASK FORCE
         Sec. 83.001.  DEFINITION. In this chapter, "task force"
  means the Chronic Kidney Disease Task Force.
         Sec. 83.002.  CHRONIC KIDNEY DISEASE TASK FORCE. (a) The
  Chronic Kidney Disease Task Force is composed of:
               (1)  20 members appointed by the governor as follows:
                     (A)  one family practice physician;
                     (B)  one pathologist;
                     (C)  one nephrologist from a nephrology
  department of a state medical school;
                     (D)  one nephrologist in private practice;
                     (E)  one representative from the National Kidney
  Foundation;
                     (F)  one representative from the Texas Kidney
  Foundation;
                     (G)  one representative from the South Plains
  Kidney Foundation of West Texas;
                     (H)  one representative from the Texas Renal
  Coalition;
                     (I)  one representative from the commission's
  Kidney Health Care Program;
                     (J)  one representative of an insurer that issues
  a preferred provider benefit plan or of a health maintenance
  organization;
                     (K)  one representative of clinical laboratories;
                     (L)  one representative of private renal care
  providers;
                     (M)  one pediatrician in private practice;
                     (N)  one kidney transplant surgeon; 
                     (O)  one primary care physician;
                     (P)  one licensed and certified renal dietitian;
                     (Q)  one certified nephrology nurse;
                     (R)  one representative from a health care system;
                     (S)  one representative of the commission whose
  duties involve the state Medicaid program; and
                     (T)  one end stage renal disease expert;
               (2)  two members of the senate appointed by the
  lieutenant governor; and
               (3)  two members of the house of representatives
  appointed by the speaker of the house of representatives.
         (b)  The governor shall designate a member of the task force
  to serve as the presiding officer of the task force. The presiding
  officer serves at the will of the governor.
         (c)  Appointments to the task force shall be made without
  regard to the race, color, disability, sex, religion, age, or
  national origin of the appointees.
         Sec. 83.003.  DUTIES. The task force shall:
               (1)  coordinate implementation of the state's
  cost-effective plan for prevention, early screening, diagnosis,
  and management of chronic kidney disease for the state's population
  through national, state, and local partners; and
               (2)  educate health care professionals on the use of
  clinical practice guidelines for screening, detecting, diagnosing,
  treating, and managing chronic kidney disease, its comorbidities,
  and its complications based on the Kidney Disease Outcomes Quality
  Initiative Clinical Practice Guidelines for Chronic Kidney
  Disease.
         Sec. 83.004.  REIMBURSEMENT. A member of the task force may
  receive reimbursement for travel expenses as provided by Section
  2110.004, Government Code.
         Sec. 83.005.  ASSISTANCE. The commission shall provide
  administrative support to the task force, including necessary staff
  and meeting facilities.
         Sec. 83.006.  REPORT. Not later than January 1 of each
  odd-numbered year, the task force shall submit its findings and
  recommendations to:
               (1)  the governor, lieutenant governor, and speaker of
  the house of representatives; and
               (2)  the presiding officers of the appropriate standing
  committees of the legislature with jurisdiction over health issues.
         Sec. 83.007.  FUNDING. (a) The task force, through the
  commission, may accept gifts and grants from individuals, private
  or public organizations, or federal or local funds to support the
  task force.
         (b)  The commission shall investigate any potential sources
  of funding from federal grants or programs.
         Sec. 83.008.  APPLICABILITY OF OTHER LAW. Except as
  specifically provided by this chapter, Chapter 2110, Government
  Code, does not apply to the task force.
         Sec. 83.009.  TASK FORCE REVIEW AND ABOLISHMENT. (a)  The
  commission shall review the continued need for the task force at
  least once every five years.
         (b)  If the commission determines the task force is no longer
  needed and should be abolished, the commission shall publish notice
  of its decision in the Texas Register and on the commission's
  Internet website.
         (c)  The task force is abolished on the date stated in the
  notice required by Subsection (b).
         SECTION 4.  Not later than January 1, 2020, the governor,
  lieutenant governor, and speaker of the house of representatives
  shall appoint the members to the Chronic Kidney Disease Task Force
  as required by Section 83.002, Health and Safety Code, as added by
  this Act.
         SECTION 5.  This Act takes effect September 1, 2019.
 
 
  ______________________________ ______________________________
     President of the Senate Speaker of the House     
 
 
         I certify that H.B. No. 1225 was passed by the House on April
  12, 2019, by the following vote:  Yeas 139, Nays 4, 2 present, not
  voting.
 
  ______________________________
  Chief Clerk of the House   
 
 
         I certify that H.B. No. 1225 was passed by the Senate on May
  20, 2019, by the following vote:  Yeas 26, Nays 5.
 
  ______________________________
  Secretary of the Senate    
  APPROVED:  _____________________
                     Date          
   
            _____________________
                   Governor       
feedback